WCBS’ CEO Radio with CEO Lori Woods on Cesium-131 making a difference treating people with cancer

Sep 3, 2020

Part 4 – Lori Woods – WCBS Radio News 8-31-2020 CEO Radio (1)

Beneath the COVID-19 headlines, WCBS’ CEO Radio talks with Isoray CEO Lori Woods about Cesium-131 internal radiation therapy and making a difference in treating people with cancer.

Investor Relations:

Mark Levin

Global IR Group

(501) 255-1910

mark@globalirgroup.com

Media and Public Relations:

Sharon Schultz
Schultz Public Relations
(302) 539-3747
schultzpr@mchsi.com

Isoray to Present at the H.C. Wainwright BioConnect 2021 Conference

Jan 7, 2021

RICHLAND, WASHINGTON – January 7, 2021 – Isoray, Inc. (NYSE American: ISR), a medical technology company and seed brachytherapy innovator powering expanding treatment options throughout the body, today announced that Chief Executive Officer Lori Woods will present at...

C4 Imaging Announces Sirius Positive Signal MRI Marker Given FDA 510(k) Clearance for Use with Isoray’s Cesium-131 Brachytherapy Seeds to Treat Prostate Cancer

Jan 6, 2021

HOUSTON, TEXAS - January 05, 2021 – C4 Imaging LLC is pleased to announce that Isoray Medical, Inc. (NYSE American: ISR) has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the use of C4 Imaging’s Sirius® positive-signal MRI (Magnetic Resonance...

StockNewsNow talks to CEO Lori Woods about company highlights, progress and her vision for Isoray’s future.

Dec 9, 2020

WCBS’ CEO Radio with CEO Lori Woods on Cesium-131 making a difference treating people with cancer

Investor Relations:

Media and Public Relations:

Isoray to Present at the H.C. Wainwright BioConnect 2021 Conference

C4 Imaging Announces Sirius Positive Signal MRI Marker Given FDA 510(k) Clearance for Use with Isoray’s Cesium-131 Brachytherapy Seeds to Treat Prostate Cancer

StockNewsNow talks to CEO Lori Woods about company highlights, progress and her vision for Isoray’s future.

About Us

Patients & Families

Doctors & Clinicians

Our Company